Methylprednisolone liposomal (EnhanX Biopharm)

甲泼尼龙脂质体 (EnhanX Biopharm)

Report date: 2025/11/17 10:08:00

Base Information

Drug NameMethylprednisolone liposomal (EnhanX Biopharm)
Drug Alias NameGlutathione PEGylated-liposomal methylprednisolone2B3-201ENX-201
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator Companies2-BBB Medicines BV
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive Companies2-BBB Medicines BV
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A